(0.18%) 5 140.75 points
(0.17%) 38 508 points
(0.26%) 17 893 points
(-0.91%) $83.09
(1.82%) $1.958
(0.06%) $2 348.70
(0.04%) $27.55
(0.52%) $926.85
(-0.17%) $0.933
(-0.16%) $11.01
(-0.25%) $0.798
(1.13%) $92.92
-0.62% £ 256.20
Live Chart Being Loaded With Signals
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes...
Stats | |
---|---|
Dagens volum | 159 074 |
Gjennomsnittsvolum | 7.72M |
Markedsverdi | 5.22B |
EPS | £0 ( 2024-03-05 ) |
Last Dividend | £1.380 ( 2023-08-17 ) |
Next Dividend | £0 ( N/A ) |
P/E | 51.24 |
ATR14 | £0.438 (0.17%) |
Volum Korrelasjon
ConvaTec Group PLC Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
GHT.L | 0.837 |
DWF.L | 0.827 |
NTOG.L | 0.817 |
3SAP.L | 0.811 |
MCM.L | 0.809 |
CNIC.L | 0.807 |
WINE.L | 0.806 |
SBEM.L | 0.805 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
ConvaTec Group PLC Korrelasjon - Valuta/Råvare
ConvaTec Group PLC Økonomi
Annual | 2023 |
Omsetning: | £2.14B |
Bruttogevinst: | £1.20B (56.04 %) |
EPS: | £0.0640 |
FY | 2023 |
Omsetning: | £2.14B |
Bruttogevinst: | £1.20B (56.04 %) |
EPS: | £0.0640 |
FY | 2022 |
Omsetning: | £2.07B |
Bruttogevinst: | £1.12B (53.92 %) |
EPS: | £0.0311 |
FY | 2021 |
Omsetning: | £2.04B |
Bruttogevinst: | £1.12B (55.10 %) |
EPS: | £0.0590 |
Financial Reports:
No articles found.
ConvaTec Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£1.410 (N/A) |
£0 (N/A) |
£0 (N/A) |
£3.66 (N/A) |
£1.380 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.061 | 2017-09-07 |
Last Dividend | £1.380 | 2023-08-17 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | £28.05 | -- |
Avg. Dividend % Per Year | 1.46% | -- |
Score | 3.56 | -- |
Div. Sustainability Score | 8.79 | |
Div.Growth Potential Score | 3.50 | |
Div. Directional Score | 6.14 | -- |
Year | Amount | Yield |
---|---|---|
2017 | £0 | 0.00% |
2018 | £4.40 | 2.05% |
2019 | £4.50 | 3.31% |
2020 | £4.40 | 2.23% |
2021 | £4.08 | 1.99% |
2022 | £4.57 | 2.36% |
2023 | £5.04 | 2.16% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PAGE.L | Dividend Knight | 2023-08-31 | Annually | 24 | 3.53% | |
FERG.L | Dividend Knight | 2023-06-15 | Semi-Annually | 32 | 1.37% | |
0KEZ.L | Dividend Junior | 2023-09-22 | Sporadic | 7 | 0.78% | |
SWEF.L | Dividend King | 2023-08-03 | Quarterly | 12 | 4.28% | |
KLR.L | Dividend King | 2023-08-17 | Semi-Annually | 31 | 2.81% | |
CEY.L | Dividend King | 2023-08-31 | Semi-Annually | 11 | 3.71% | |
RCDO.L | Dividend Junior | 2023-11-02 | Annually | 32 | 0.96% | |
GLE.L | Dividend Junior | 2023-10-26 | Annually | 32 | 1.19% | |
ANTO.L | Dividend Knight | 2023-08-31 | Semi-Annually | 32 | 2.90% | |
TRD.L | Dividend Junior | 2023-07-13 | Annually | 29 | 3.35% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0608 | 1.500 | 8.78 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0351 | 1.200 | 8.83 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0785 | 1.500 | -0.239 | -0.358 | [0.1 - 1] |
payoutRatioTTM | 0.850 | -1.000 | 1.504 | -1.504 | [0 - 1] |
currentRatioTTM | 1.622 | 0.800 | 6.89 | 5.51 | [1 - 3] |
quickRatioTTM | 0.686 | 0.800 | -0.669 | -0.535 | [0.8 - 2.5] |
cashRatioTTM | 0.182 | 1.500 | -0.100 | -0.150 | [0.2 - 2] |
debtRatioTTM | 0.353 | -1.500 | 4.11 | -6.17 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.177 | 2.00 | 9.94 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.115 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.775 | -1.500 | 6.90 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.562 | 1.000 | 3.97 | 3.97 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.131 | 1.000 | 9.39 | 9.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.577 | 0.800 | 9.49 | 7.59 | [0.5 - 2] |
Total Score | 8.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 51.41 | 1.000 | 4.91 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0785 | 2.50 | -0.153 | -0.358 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.115 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.515 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.177 | 2.00 | 9.94 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.850 | 1.500 | 1.504 | -1.504 | [0 - 1] |
pegRatioTTM | -63.57 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.171 | 1.000 | 8.21 | 0 | [0.1 - 0.5] |
Total Score | 3.50 |
ConvaTec Group PLC
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.